NYMOX PHARMACEUTICAL CORP (NYMXF) SEC Filings & Financial Intelligence
NYMOX PHARMACEUTICAL CORP (NYMXF) is a publicly traded company on the OTC, categorized under SIC 2835 (In Vitro & In Vivo Diagnostic Substances). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: NYMXF
CIK: 1018735
Exchange: OTC
SIC 2835: In Vitro & In Vivo Diagnostic Substances
Fiscal Year End: 12/31
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
M&K CPAS, PLLC
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerCecil Garrick
Audit LocationThe Woodlands, Texas, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 20-F/A | 2026-09-29 | 2025-12-31 | FORM 20-F/A | 0001640334-26-001603 | View SEC Doc Filr Page |
| 20-F/A | 2026-09-16 | 2025-12-31 | FORM 20-F/A | 0001640334-26-001557 | View SEC Doc Filr Page |
| 20-F | 2026-09-14 | 2025-12-31 | FORM 20-F | 0001640334-26-001515 | View SEC Doc Filr Page |
| 6-K | 2026-08-31 | 2026-08-31 | FORM 6-K | 0001640334-26-001427 | View SEC Doc Filr Page |
| 6-K | 2026-08-07 | 2026-08-07 | FORM 6-K | 0001640334-26-001291 | View SEC Doc Filr Page |
| 6-K | 2026-06-03 | 2026-06-02 | FORM 6-K | 0001640334-26-000983 | View SEC Doc Filr Page |
| 6-K | 2026-03-27 | 2026-03-27 | FORM 6-K | 0001640334-26-000562 | View SEC Doc Filr Page |
| 6-K | 2025-11-07 | 2025-11-07 | FORM 6-K | 0001640334-25-001988 | View SEC Doc Filr Page |
| 6-K | 2025-10-22 | 2025-10-22 | FORM 6-K | 0001640334-25-001864 | View SEC Doc Filr Page |
| 6-K | 2025-10-22 | 2025-10-22 | FORM 6-K | 0001640334-25-001862 | View SEC Doc Filr Page |
| 6-K | 2025-09-23 | 2025-09-23 | FORM 6-K | 0001640334-25-001701 | View SEC Doc Filr Page |
| 20-F | 2025-06-03 | 2024-12-31 | FORM 20-F | 0001640334-25-000972 | View SEC Doc Filr Page |
| 6-K | 2025-05-22 | 2025-05-22 | FORM 6-K | 0001640334-25-000923 | View SEC Doc Filr Page |
| NT 20-F | 2025-05-01 | 2024-12-31 | FORM 20-F | 0001640334-25-000728 | View SEC Doc Filr Page |
| 6-K | 2025-03-11 | 2025-03-11 | FORM 6-K | 0001640334-25-000362 | View SEC Doc Filr Page |
| 6-K | 2025-01-02 | 2024-09-30 | FORM 6-K | 0001640334-25-000006 | View SEC Doc Filr Page |
| 6-K | 2024-12-17 | 2024-12-17 | FORM 6-K | 0001640334-24-001904 | View SEC Doc Filr Page |
| 20-F | 2024-08-29 | 2023-12-31 | FORM 20-F | 0001640334-24-001383 | View SEC Doc Filr Page |
| 6-K | 2024-07-18 | 2024-07-18 | FORM 6-K | 0001640334-24-001139 | View SEC Doc Filr Page |
| 6-K | 2024-07-16 | 2024-07-17 | FORM 6-K | 0001640334-24-001122 | View SEC Doc Filr Page |
| 6-K | 2024-05-13 | 2024-05-13 | FORM 6-K | 0001640334-24-000763 | View SEC Doc Filr Page |
| 6-K | 2024-03-28 | 2024-03-28 | FORM 6-K | 0001640334-24-000510 | View SEC Doc Filr Page |
| 6-K | 2023-11-15 | 2023-09-30 | FORM 6-K | 0001640334-23-002155 | View SEC Doc Filr Page |
| 6-K | 2023-11-09 | 2023-11-09 | FORM 6-K | 0001640334-23-002040 | View SEC Doc Filr Page |
| 6-K | 2023-11-06 | 2023-11-03 | FORM 6-K | 0001640334-23-002021 | View SEC Doc Filr Page |